These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Present status and future of hypnotic drug treatment for insomnia]. Uchiyama M; Konno M Nihon Rinsho; 2012 Jul; 70(7):1241-51. PubMed ID: 22844812 [TBL] [Abstract][Full Text] [Related]
3. Drugs for insomnia. Zisapel N Expert Opin Emerg Drugs; 2012 Sep; 17(3):299-317. PubMed ID: 22681198 [TBL] [Abstract][Full Text] [Related]
4. [Appropriate Use and Abuse of Sedative-Hypnotic Drugs]. Zheng JW; Meng SQ; Liu WY; Chang XW; Shi J Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):231-239. PubMed ID: 36949678 [TBL] [Abstract][Full Text] [Related]
8. Making sleep easier: pharmacological interventions for insomnia. Frase L; Nissen C; Riemann D; Spiegelhalder K Expert Opin Pharmacother; 2018 Sep; 19(13):1465-1473. PubMed ID: 30175928 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological advances in the treatment of insomnia. Richey SM; Krystal AD Curr Pharm Des; 2011; 17(15):1471-5. PubMed ID: 21476952 [TBL] [Abstract][Full Text] [Related]
10. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740 [TBL] [Abstract][Full Text] [Related]
11. An assessment of short-acting hypnotics. Mendelson WB; Jain B Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298 [TBL] [Abstract][Full Text] [Related]
12. Hypnotics with novel modes of action. Hoyer D; Allen A; Jacobson LH Br J Clin Pharmacol; 2020 Feb; 86(2):244-249. PubMed ID: 31756268 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment of disturbed sleep in the elderly. Salzman C Harv Rev Psychiatry; 2008; 16(5):271-8. PubMed ID: 18803102 [TBL] [Abstract][Full Text] [Related]
14. Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database. Okuda S; Qureshi ZP; Yanagida Y; Ito C; Homma Y; Tokita S BMC Psychiatry; 2023 Apr; 23(1):278. PubMed ID: 37081408 [TBL] [Abstract][Full Text] [Related]
17. [Research progress in pharmacotherapy of insomnia]. Hu J; Wei SS; Jiang HZ; Luo JY; Yang W; Zhang YM; Wang XB; Wen CN Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5122-5130. PubMed ID: 38114102 [TBL] [Abstract][Full Text] [Related]
18. Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Winrow CJ; Renger JJ Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216 [TBL] [Abstract][Full Text] [Related]
19. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs]. Zisapel N Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367 [TBL] [Abstract][Full Text] [Related]
20. Main neuroendocrine features and therapy in primary sleep troubles. Amihăesei IC; Mungiu OC Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]